Search:


Media Contact
Annette Ballou
Email
216.658.3999
Newsroom > News
print
The City of Akron announced yesterday the creation of the Akron BioInvestments Fund, a partnership to be managed by the Akron Development Corporation. The seed fund will target national and international businesses in orthopedics, wound healing, cardiovascular, biomaterials, and health care information technology companies.

Click here to read more from the Akron Beacon Journal.

Recent News

»  Great Lakes NeuroTechnologies Receives $4.5 Million

»  Life Core Technologies Raises Seed Funding

»  Research Organics acquired by Sigma-Aldrich

»  CardioInsight Raises $7.5 Million

»  ViewRay Raises $16 Million




The 2012 Venture Report

Cleveland:
Health Care Innovation Destination

» View / Download






Sign Up for BioEnterprise eNews

Add me to your emailing list: sign up




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
 
Copyright © 2012 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999